Results of a phase I/II single arm clinical trial assessing the recombinant Bacillus Calmette-Guerin (rBCG) VPM1002BC in patients with non muscle-invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy - SAKK 06/14
VPM1002BC;BCG Maintenance Therapy
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Results of a phase I/II single arm clinical trial assessing the recombinant Bacillus Calmette-Guerin (rBCG) VPM1002BC in patients with non muscle-invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy - SAKK 06/14 ### Output: VPM1002BC;BCG Maintenance Therapy